The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours - Bodei, L; Mueller-Brand, J; Baum, RP (Eur J Nucl Med Mol Imaging, 2013)
et al.